A bidding war has broken out over Biosite (BSTE). Inverness Medical Innovations (IMA), which already owns 4.9% of Biosite’s outstanding stock, offered $90 for the rest. >>> Discuss This Story
A bidding war has broken out over Biosite (BSTE). Inverness Medical Innovations (IMA), which already owns 4.9% of Biosite’s outstanding stock, offered $90 for the rest. >>> Discuss This Story